Skip to menu Skip to content Skip to footer

Exploring the impact of BUsulfan METabolites on busulfan clearance, exposure and patient outcomes following Haematopoietic Stem Cell Transplantation (BU-MET-HSCT). (QHCRF administered by CHQ HHS) (2024-2026)

Experts

Dr Christine Staatz

Associate Professor
School of Pharmacy and Pharmaceutical Sciences
Faculty of Health, Medicine and Behavioural Sciences
Christine Staatz
Christine Staatz